 | • レポートコード：PMR201120 • 出版社/出版日：Persistence Market Research / 2020年8月20日 • レポート形態：英文、PDF、300ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、グライコバイオロジーの世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、市場需要分析・予測、市場価格分析・予測、製品別（機器、酵素、消耗品、試薬キット）分析、酵素別（ガラクトシダーゼ、GlcNAcトランスフェラーゼ、フコシルトランスフェラーゼ、GalNAcトランスフェラーゼ、ガラクトシルトランスフェラーゼ）分析、用途別（創薬・開発、診断、産業、治療、その他）分析、エンドユーザー別（バイオ製薬会社、研究所、病院、診断センター、委託研究機関）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・市場需要分析・予測 ・市場価格分析・予測 ・グライコバイオロジーの世界市場規模：製品別（機器、酵素、消耗品、試薬キット） ・グライコバイオロジーの世界市場規模：酵素別（ガラクトシダーゼ、GlcNAcトランスフェラーゼ、フコシルトランスフェラーゼ、GalNAcトランスフェラーゼ、ガラクトシルトランスフェラーゼ） ・グライコバイオロジーの世界市場規模：用途別（創薬・開発、診断、産業、治療、その他） ・グライコバイオロジーの世界市場規模：エンドユーザー別（バイオ製薬会社、研究所、病院、診断センター、委託研究機関） ・グライコバイオロジーの世界市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Glycobiology Market – Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global glycobiology market. The study provides detailed assessment of key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the glycobiology market structure. The market study presents exclusive information about how the glycobiology market will grow during the forecast period (2020-2030).
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compound annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes definitions, drivers, and opportunity analysis by region and by product, which helps in the deep understanding of the market segment details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the glycobiology market during the forecast period.
The study is relevant for manufacturers, physicians, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researchers, shareholders, and industry experts can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the glycobiology market. Furthermore, small businesses and new entrants in the glycobiology market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
PMR’s study on the glycobiology market offers information divided into five important segments—product, enzyme, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Questions Answered in PMR’s Glycobiology Market Report
Which regions will continue to remain the most profitable regional markets for glycobiology market players?
Which factors will induce a change in the demand for glycobiology during the assessment period?
What are the different opportunities available for emerging players in the glycobiology market?
How are supply-side and demand-side drivers impacting the glycobiology market?
How will changing trends impact the glycobiology market?
How can market players capture the low-hanging opportunities in the glycobiology market in developed regions?
Which companies are leading the glycobiology market?
What are the winning strategies of stakeholders in the glycobiology market to upscale their position in this landscape?
Glycobiology Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the glycobiology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the glycobiology market study include statistics from government healthcare organizations, medicines journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the glycobiology market, and makes PMR’s projections on the growth prospects of the glycobiology market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Glycobiology Adoption Rate/Usage Analysis- Key Statistics
4.2. Key Promotional Strategies, By Key Manufacturers
4.3. Key Regulations, By Region
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Market Outlook
5.1.3. Global Life Science Market Outlook
5.1.4. Global Cancer Diagnostic Market Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Key Players Historical Growth
5.2.2. Market Consolidation Activities
5.2.3. Availability of Glycobiology Across Regions
5.2.4. Cost of Product & Services
5.2.5. Product Adoption
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
5.4. COVID19 Crisis Analysis
5.4.1. Current COVID19 Statistics and Probable Future Impact
5.4.2. Current GDP Projection and Probable Impact
5.4.3. Current Economic Projection as compared to 2008 financial analysis
5.4.4. COVID19 and Impact Analysis
5.4.4.1. Revenue By Product
5.4.4.2. Revenue By Enzyme Type
5.4.4.3. Revenue By Application
5.4.4.4. Revenue By Country
5.4.5. 2020 Market Scenario
5.4.6. Quarter by Quarter Forecast
5.4.7. Projected recovery Quarter
5.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Global Glycobiology Market Demand (in Volume units) Analysis 2015–2019 and Forecast, 2020–2030
6.1. Historical Market Volume (Units) Analysis, 2015-2020
6.2. Current and Future Market Volume (Units) Projections, 2020-2030
6.3. Y-o-Y Growth Trend Analysis
7. Global Glycobiology Market Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global Glycobiology Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
8.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
8.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Product, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2020-2030
9.3.1. Instruments
9.3.2. Enzymes
9.3.3. Consumables
9.3.4. Reagent Kits
9.4. Market Attractiveness Analysis by Product
10. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Enzyme
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Enzyme, 2015-2019
10.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Enzyme, 2020-2030
10.3.1. Galactosidases
10.3.1.1. Fucosidases
10.3.1.2. Chitinases
10.3.1.3. Acetylgalactosaminidase
10.3.1.4. Heparinase
10.3.1.5. PNGase F
10.3.1.6. Others
10.3.2. GlcNAc Transferases
10.3.2.1. Acetylglucosaminyl transferase
10.3.2.2. Exostosin
10.3.2.3. Others
10.3.3. Fucosyltransferases
10.3.4. GalNAc Transferases
10.3.5. Galactosyl Transferases
10.3.6. Glucuronosyltransferases
10.3.7. Glucosyltransferases
10.3.8. Pentosyltransferases
10.3.9. Carbohydrate Kinases
10.3.10. Neuraminidases
10.3.11. Sialyltransferases
10.3.12. Others
10.4. Market Attractiveness Analysis By Enzyme
11. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and By Application, 2015-2019
11.3. Current and Future Market Size (US$ Mn) and Forecast By Application, 2020-2030
11.3.1.1. Drug Discovery and Development
11.3.1.2. Diagnostic Applications
11.3.1.2.1. Oncology
11.3.1.2.2. Immunology
11.3.1.2.3. Others
11.3.1.3. Industrial Application
11.3.1.4. Therapeutic Application
11.3.1.4.1. Oncology
11.3.1.4.2. Immunology
11.3.1.4.3. Others
11.3.1.5. Others
11.4. Market Attractiveness Analysis by Application
12. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
12.3.1.1. Biopharmaceutical Companies
12.3.1.2. Research Laboratories
12.3.1.3. Hospitals
12.3.1.4. Diagnostic Centers
12.3.1.5. Contract Research Organizations
12.3.1.6. Biotechnology Industries
12.3.1.7. Academic Institutes
12.3.1.8. Others
12.4. Market Attractiveness Analysis By End User
13. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Enzyme
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
15. Latin America Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Enzyme
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
16. Europe Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Enzyme
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
17. South Asia Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Enzyme
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
18. East Asia Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Enzyme
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints – Impact Analysis
19. Oceania Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Enzyme
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
19.7. Drivers and Restraints – Impact Analysis
20. Middle East and Africa Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Enzyme
20.3.4. By Application
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.5. Market Trends
20.6. Key Market Participants – Intensity Mapping
20.7. Drivers and Restraints – Impact Analysis
21. Key and Emerging Countries Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Glycobiology Market Analysis
21.2.1. By Product
21.2.2. By Enzyme
21.2.3. By Application
21.2.4. By End User
21.3. Canada Glycobiology Market Analysis
21.3.1. By Product
21.3.2. By Enzyme
21.3.3. By Application
21.3.4. By End User
21.4. Mexico Glycobiology Market Analysis
21.4.1. By Product
21.4.2. By Enzyme
21.4.3. By Application
21.4.4. By End User
21.5. Brazil Glycobiology Market Analysis
21.5.1. By Product
21.5.2. By Enzyme
21.5.3. By Application
21.5.4. By End User
21.6. U.K. Glycobiology Market Analysis
21.6.1. By Product
21.6.2. By Enzyme
21.6.3. By Application
21.6.4. By End User
21.7. Germany Glycobiology Market Analysis
21.7.1. By Product
21.7.2. By Enzyme
21.7.3. By Application
21.7.4. By End User
21.8. France Glycobiology Market Analysis
21.8.1. By Product
21.8.2. By Enzyme
21.8.3. By Application
21.8.4. By End User
21.9. Italy Glycobiology Market Analysis
21.9.1. By Product
21.9.2. By Enzyme
21.9.3. By Application
21.9.4. By End User
21.10. Spain Glycobiology Market Analysis
21.10.1. By Product
21.10.2. By Enzyme
21.10.3. By Application
21.10.4. By End User
21.11. BENELUX Glycobiology Market Analysis
21.11.1. By Product
21.11.2. By Enzyme
21.11.3. By Application
21.11.4. By End User
21.12. Russia Glycobiology Market Analysis
21.12.1. By Product
21.12.2. By Enzyme
21.12.3. By Age Group
21.12.4. By End User
21.13. China Glycobiology Market Analysis
21.13.1. By Product
21.13.2. By Enzyme
21.13.3. By Application
21.13.4. By End User
21.14. Japan Glycobiology Market Analysis
21.14.1. By Product
21.14.2. By Enzyme
21.14.3. By Application
21.14.4. By End User
21.15. South Korea Glycobiology Market Analysis
21.15.1. By Product
21.15.2. By Enzyme
21.15.3. By Application
21.15.4. By End User
21.16. India Glycobiology Market Analysis
21.16.1. By Product
21.16.2. By Enzyme
21.16.3. By Application
21.16.4. By End User
21.17. ASEAN Glycobiology Market Analysis
21.17.1. By Product
21.17.2. By Enzyme
21.17.3. By Application
21.17.4. By End User
21.18. Australia Glycobiology Market Analysis
21.18.1. By Product
21.18.2. By Enzyme
21.18.3. By Application
21.18.4. By End User
21.19. New Zealand Glycobiology Market Analysis
21.19.1. By Product
21.19.2. By Enzyme
21.19.3. By Application
21.19.4. By End User
21.20. GCC Countries Glycobiology Market Analysis
21.20.1. By Product
21.20.2. By Enzyme
21.20.3. By Application
21.20.4. By End User
21.21. Turkey Glycobiology Market Analysis
21.21.1. By Product
21.21.2. By Enzyme
21.21.3. By Application
21.21.4. By End User
21.22. South Africa Glycobiology Market Analysis
21.22.1. By Product
21.22.2. By Enzyme
21.22.3. By Application
21.22.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1.1. Regional footprint of Players
22.4.1.2. Product foot print by Players
22.4.1.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Pricing Analysis by Competition
23.3. Competition Benchmarking
23.4. Competition Deep Dive
23.4.1. Merck KGaA
23.4.1.1. Overview
23.4.1.2. Product Portfolio
23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
23.4.1.4. Sales Footprint
23.4.1.5. Analyst Commentary
23.4.1.6. Strategy Overview
23.4.1.6.1. Marketing Strategy
23.4.1.6.2. Product Strategy
23.4.1.6.3. Channel Strategy
23.4.2. Bio-Techne Corporation
23.4.2.1. Overview
23.4.2.2. Product Portfolio
23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
23.4.2.4. Sales Footprint
23.4.2.5. Analyst Commentary
23.4.2.6. Strategy Overview
23.4.2.6.1. Marketing Strategy
23.4.2.6.2. Product Strategy
23.4.2.6.3. Channel Strategy
23.4.3. Bruker Corporation
23.4.3.1. Overview
23.4.3.2. Product Portfolio
23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
23.4.3.4. Sales Footprint
23.4.3.5. Analyst Commentary
23.4.3.6. Strategy Overview
23.4.3.6.1. Marketing Strategy
23.4.3.6.2. Product Strategy
23.4.3.6.3. Channel Strategy
23.4.4. Thermo Fisher Scientific, Inc.
23.4.4.1. Overview
23.4.4.2. Product Portfolio
23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
23.4.4.4. Sales Footprint
23.4.4.5. Analyst Commentary
23.4.4.6. Strategy Overview
23.4.4.6.1. Marketing Strategy
23.4.4.6.2. Product Strategy
23.4.4.6.3. Channel Strategy
23.4.5. Shimadzu Corporation
23.4.5.1. Overview
23.4.5.2. Product Portfolio
23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
23.4.5.4. Sales Footprint
23.4.5.5. Analyst Commentary
23.4.5.6. Strategy Overview
23.4.5.6.1. Marketing Strategy
23.4.5.6.2. Product Strategy
23.4.5.6.3. Channel Strategy
23.4.6. ProZyme Inc.
23.4.6.1. Overview
23.4.6.2. Product Portfolio
23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
23.4.6.4. Sales Footprint
23.4.6.5. Analyst Commentary
23.4.6.6. Strategy Overview
23.4.6.6.1. Marketing Strategy
23.4.6.6.2. Product Strategy
23.4.6.6.3. Channel Strategy
23.4.7. NEB Inc.
23.4.7.1. Overview
23.4.7.2. Product Portfolio
23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
23.4.7.4. Sales Footprint
23.4.7.5. Analyst Commentary
23.4.7.6. Strategy Overview
23.4.7.6.1. Marketing Strategy
23.4.7.6.2. Product Strategy
23.4.7.6.3. Channel Strategy
23.4.8. Agilent Technologies
23.4.8.1. Overview
23.4.8.2. Product Portfolio
23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
23.4.8.4. Sales Footprint
23.4.8.5. Analyst Commentary
23.4.8.6. Strategy Overview
23.4.8.6.1. Marketing Strategy
23.4.8.6.2. Product Strategy
23.4.8.6.3. Channel Strategy
23.4.9. New England Biolabs
23.4.9.1. Overview
23.4.9.2. Product Portfolio
23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
23.4.9.4. Sales Footprint
23.4.9.5. Analyst Commentary
23.4.9.6. Strategy Overview
23.4.9.6.1. Marketing Strategy
23.4.9.6.2. Product Strategy
23.4.9.6.3. Channel Strategy
23.4.10. Takara Bio
23.4.10.1. Overview
23.4.10.2. Product Portfolio
23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
23.4.10.4. Sales Footprint
23.4.10.5. Analyst Commentary
23.4.10.6. Strategy Overview
23.4.10.6.1. Marketing Strategy
23.4.10.6.2. Product Strategy
23.4.10.6.3. Channel Strategy
23.4.11. Waters Corporation
23.4.11.1. Overview
23.4.11.2. Product Portfolio
23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
23.4.11.4. Sales Footprint
23.4.11.5. Analyst Commentary
23.4.11.6. Strategy Overview
23.4.11.6.1. Marketing Strategy
23.4.11.6.2. Product Strategy
23.4.11.6.3. Channel Strategy
23.4.12. Danaher Corporation
23.4.12.1. Overview
23.4.12.2. Product Portfolio
23.4.12.3. Profitability by Market Segments (Product/Channel/Region)
23.4.12.4. Sales Footprint
23.4.12.5. Analyst Commentary
23.4.12.6. Strategy Overview
23.4.12.6.1. Marketing Strategy
23.4.12.6.2. Product Strategy
23.4.12.6.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Table 01: Global Glycobiology Market Volume (‘000 Units) Analysis and Opportunity Assessment 2015–2030, By ProductTable 02: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 03: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 04: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 05: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 06: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 07: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 08: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 09: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 10: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 11: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 12: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 13: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 14: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 15: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 16: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 17: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 18: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 19: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 20: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 21: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 22: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 23: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 24: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 25: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 26: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 27: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 28: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 29: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 30: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 31: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 32: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 33: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 34: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 35: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 36: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 37: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 38: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product
Table 39: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Enzyme
Table 40: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 41: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User